Trial Profile
Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 05 Nov 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 13 Oct 2014 New trial record